Verified Nov 2026
Electronics & Software
·
Manchester, New Hampshire
·
Since 2023
Sequel Med Tech is a privately held medical technology company founded in 2023 and headquartered in Manchester, New Hampshire, with an additional office in Marlborough, Massachusetts. It employs an estimated 200 to 500 people and has an estimated annual revenue band of $100 million to $250 million. The company develops automated insulin delivery systems for people with diabetes, and its flagship twiist® Automated Insulin Delivery System, which was launched in July 2025, is an FDA-cleared device that delivers insulin in microdoses based on real-time glucose data. The company also serves the automotive, electric-vehicle, medical, and industrial-equipment sectors.
Sequel Med Tech at a glance
Revenue
$100-250M
Est. band
Employees
200-500
Founded
2023
Headquarters
Manchester, New Hampshire
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
STABILITY SIGNALS
Established & active
3 years in operation (founded 2023).
Holds ISO 13485 certification(s) per public sources.
Overview
Sequel Med Tech is a privately held medical technology company founded in 2023 and headquartered in Manchester, New Hampshire, with an additional office in Marlborough, Massachusetts. It employs an estimated 200 to 500 people and has an estimated annual revenue band of $100 million to $250 million. The company develops automated insulin delivery systems for people with diabetes, and its flagship twiist® Automated Insulin Delivery System, which was launched in July 2025, is an FDA-cleared device that delivers insulin in microdoses based on real-time glucose data. The company also serves the automotive, electric-vehicle, medical, and industrial-equipment sectors.
At a glance
Attribute | Detail |
|---|---|
Founded | 2023 |
Headquarters | Manchester, New Hampshire |
Employees | 200-500 |
Revenue | $100-250M (estimated) |
Primary capability | Electronics & Software |
Certifications | ISO 13485 |
What Sequel Med Tech makes
The company holds ISO 13485 certification and its product line includes a sensor and an insulin pump.
Products and capabilities described on the company's own site include Sensor, Pump (source: sequelmedtech.com).
Certifications
Sequel Med Tech is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — sequelmedtech.com
Latest developments
2026-06-09 — Sequel Med Tech CMO: company is 'excited about what's ahead' (drugdeliverybusiness.com)
2026-03-24 — Sequel Med Tech (sequelmedtech.com)
2026-02-19 — Sequel Med Tech and Senseonics Launch Transformative (globenewswire.com)
2025-09-25 — Sequel Med Tech, Arecor ink co-dev deal for ultra-rapid insulin (drugdeliverybusiness.com)
2025-09-25 — Ligand Pharmaceuticals Incorporated - Arecor announces Sale of Royalty Rights and Technology Access Fees for AT220 and AT292 (ligand.com)
2025-09-25 — Sequel Med Tech taps Arecor to test its twiist pump with ultra-concentrated insulin (fiercebiotech.com)
Company details
Sequel Med Tech was co-founded by Dean Kamen and Alan Lotvin, MD, and in February 2026 it launched a product collaboration with Senseonics, as reported by GlobeNewswire. Sequel Med Tech was founded in 2023, has an estimated 200-500 employees, and is headquartered in Manchester, New Hampshire. On the LightSource stability read it is rated "Established & active": 3 years in operation (founded 2023). Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Sequel Med Tech make?
Sequel Med Tech is a privately held medical technology company founded in 2023 and headquartered in Manchester, New Hampshire, with an additional office in Marlborough, Massachusetts. It employs an estimated 200 to 500 people and has an estimated annual revenue band of $100 million to $250 million. The company develops automated insulin delivery systems for people with diabetes, and its flagship twiist® Automated Insulin Delivery System, which was launched in July 2025, is an FDA-cleared device that delivers insulin in microdoses based on real-time glucose data. The company also serves the automotive, electric-vehicle, medical, and industrial-equipment sectors.
Where is Sequel Med Tech headquartered?
Sequel Med Tech is headquartered in Manchester, New Hampshire (50 Commercial St, Manchester, New Hampshire, 03101).
When was Sequel Med Tech founded?
Sequel Med Tech was founded in 2023.
How big is Sequel Med Tech?
Sequel Med Tech has an estimated 200-500 employees, with revenue in the $100-250M range (estimated).
What certifications does Sequel Med Tech hold?
Sequel Med Tech lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.